Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients.
NCT01957423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2013-10-08
Summary
The objective of this study was to evaluate the effect of Whey Protein (WP) and Soy Protein (SP) nutritional supplements on nutritional status and disease activity in Crohn's disease patients.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Whey protein
Whey protein was provided as sachets with 15g. Patients were advised to consume two sachets per day (amounting to 22.4g of protein) mixed with food or a cold beverage, for 16 weeks. All patients remained on an unrestricted diet and did not receive nutritional advice.
- DIETARY_SUPPLEMENT
-
Soy protein
Soy protein was provided as sachets with 15g. Patients were advised to consume two sachets per day (amounting to 22.4g of protein) mixed with food or a cold beverage, for 16 weeks. All patients remained on an unrestricted diet and did not receive nutritional advice.
Sponsors & Collaborators
-
Fundação de Amparo à Pesquisa do Estado de São Paulo
collaborator OTHER_GOV -
University of Campinas, Brazil
lead OTHER
Principal Investigators
-
Maria MS Vilela, MD PhD · University of Campinas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-03-31
- Completion
- 2013-03-31
Countries
- Brazil
Study Locations
More Related Trials
-
Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease
NCT03012542 ·Status: UNKNOWN ·Phase: NA
-
L-carnitine to Treat Fatigue Associated With Crohn's Disease
NCT01523106 ·Status: WITHDRAWN ·Phase: NA
-
Vitamin D Supplementation in Crohn's Patients
NCT00742781 ·Status: COMPLETED ·Phase: PHASE1
-
ProteIn Nutrition in Crohn's Disease
NCT05572008 ·Status: UNKNOWN ·Phase: NA
-
Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease
NCT04283864 ·Status: ACTIVE_NOT_RECRUITING
-
Protein and Energy Metabolism in Pediatric Crohn's Disease
NCT00583232 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery
NCT04160325 ·Status: RECRUITING ·Phase: NA
-
Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
NCT00790543 ·Status: COMPLETED
-
Impact of Different Dietary IgGs on the Pathogenesis of IBD
NCT03885479 ·Status: UNKNOWN
-
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
NCT02649075 ·Status: TERMINATED ·Phase: NA
-
Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in Adult
NCT02056418 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Exclusion Diet for Crohn's Disease Plus Enteral Nutrition on Children and Adolescents With Crohn's Disease
NCT06353633 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Phenotyping of Adult Crohn's Focusing on Sarcopenia
NCT05572203 ·Status: UNKNOWN ·Phase: NA
-
Chronic Inflammatory Disease, Lifestyle and Treatment Response
NCT03173144 ·Status: COMPLETED
-
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease
NCT04135027 ·Status: UNKNOWN
-
Partial-enteral Nutrition Protocol for Crohn's Disease
NCT07113431 ·Status: COMPLETED ·Phase: NA
-
Protease Regulation and Impact of Sodium as Mechanisms of Inflammation in IBD
NCT07169123 ·Status: NOT_YET_RECRUITING
-
The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD)
NCT01823042 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission
NCT02044952 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's Disease
NCT01540942 ·Status: COMPLETED ·Phase: NA
-
Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn's Disease
NCT04272788 ·Status: COMPLETED
-
Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders
NCT01540292 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of CDED With Anti-TNF-α Biologics in Crohn's Disease
NCT07344428 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Food and Crohn's Exacerbation Study (FACES)
NCT01926730 ·Status: COMPLETED ·Phase: NA
-
A Culturally Tailored Dietary Intervention to Treat Crohn's Disease
NCT05627128 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA